| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.847 | 0.01 | 0.91 | Antiinflammatory | 0.91 0.005 CID_154699522 | CID_154699522 | |
| 0.755 | 0.004 | 0.755 | Immunosuppressant | 0.689 0.005 CID_154699522 | ||
| 0.77 | 0.02 | 0.855 | Apoptosis agonist | 0.855 0.01 CID_154699522 | CID_154699522 | |
| 0.611 | 0.003 | 0.881 | Expectorant | 0.881 0.001 CID_154699522 | CID_154699522 | |
| 0.622 | 0.029 | 0.816 | Transcription factor NF kappa B inhibitor | 0.816 0.012 CID_154699522 | CID_154699522 | |
| 0.588 | 0.01 | 0.621 | Nitric oxide antagonist | 0.621 0.009 CID_154699522 | CID_154699522 | |
| 0.532 | 0.032 | 0.745 | Antibacterial | 0.745 0.006 CID_154699522 | CID_154699522 | |
| 0.508 | 0.01 | 0.528 | Psychostimulant | 0.528 0.009 CID_154699522 | CID_154699522 | |
| 0.469 | 0.005 | 0.469 | 5 Hydroxytryptamine uptake stimulant | 0.191 0.17 CID_154699522 | ||
| 0.469 | 0.008 | 0.544 | Melanin inhibitor | 0.544 0.005 CID_154699522 | CID_154699522 | |
| 0.429 | 0.004 | 0.429 | Vanilloid agonist | 0.21 0.006 CID_154699522 | ||
| 0.449 | 0.032 | 0.449 | Immunomodulator | 0.436 0.034 CID_154699522 | ||
| 0.375 | 0.003 | 0.375 | Mucolytic | 0.372 0.003 CID_154699522 | ||
| 0.453 | 0.082 | 0.519 | Caspase 9 stimulant | 0.519 0.053 CID_154699522 | CID_154699522 | |
| 0.383 | 0.024 | 0.57 | DNA synthesis inhibitor | 0.57 0.009 CID_154699522 | CID_154699522 | |
| 0.374 | 0.027 | 0.79 | Angiogenesis stimulant | 0.79 0.004 CID_154699522 | CID_154699522 | |
| 0.337 | 0.004 | 0.455 | ATPase inhibitor | 0.455 0.003 CID_154699522 | CID_154699522 | |
| 0.363 | 0.043 | 0.615 | Antioxidant | 0.615 0.01 CID_154699522 | CID_154699522 | |
| 0.334 | 0.016 | 0.418 | Interferon gamma antagonist | 0.418 0.01 CID_154699522 | CID_154699522 | |
| 0.342 | 0.035 | 0.436 | Vasodilator | 0.436 0.018 CID_154699522 | CID_154699522 | |
| 0.329 | 0.025 | 0.477 | Platelet adhesion inhibitor | 0.477 0.006 CID_154699522 | CID_154699522 | |
| 0.359 | 0.061 | 0.659 | Cholesterol antagonist | 0.659 0.011 CID_154699522 | CID_154699522 | |
| 0.348 | 0.06 | 0.591 | Caspase 3 stimulant | 0.591 0.011 CID_154699522 | CID_154699522 | |
| 0.297 | 0.01 | 0.457 | Antineoplastic antibiotic | 0.457 0.004 CID_154699522 | CID_154699522 | |
| 0.295 | 0.017 | 0.427 | Protein kinase stimulant | 0.427 0.007 CID_154699522 | CID_154699522 | |
| 0.324 | 0.058 | 0.442 | Interleukin 2 agonist | 0.442 0.017 CID_154699522 | CID_154699522 | |
| 0.305 | 0.045 | 0.408 | Interleukin agonist | 0.408 0.018 CID_154699522 | CID_154699522 | |
| 0.32 | 0.063 | 0.423 | Spasmolytic | 0.423 0.036 CID_154699522 | CID_154699522 | |
| 0.261 | 0.006 | 0.262 | Microtubule formation inhibitor | 0.262 0.006 CID_154699522 | CID_154699522 | |
| 0.252 | 0.006 | 0.252 | GABA C receptor antagonist | |||
| 0.264 | 0.021 | 0.317 | Alpha-N-acetylglucosaminidase inhibitor | 0.317 0.014 CID_154699522 | CID_154699522 | |
| 0.316 | 0.074 | 0.565 | Immunostimulant | 0.565 0.021 CID_154699522 | CID_154699522 | |
| 0.236 | 0.004 | 0.236 | Ca(v)3.1 blocker | 0.094 0.03 CID_154699522 | ||
| 0.281 | 0.049 | 0.281 | Antimitotic | |||
| 0.268 | 0.036 | 0.389 | Non-steroidal antiinflammatory agent | 0.389 0.015 CID_154699522 | CID_154699522 | |
| 0.311 | 0.081 | 0.311 | Calcium channel activator | |||
| 0.302 | 0.084 | 0.508 | Apoptosis antagonist | 0.508 0.019 CID_154699522 | CID_154699522 | |
| 0.23 | 0.021 | 0.23 | Cholesterol synthesis inhibitor | 0.16 0.04 CID_154699522 | ||
| 0.27 | 0.066 | 0.413 | Tumour necrosis factor alpha release inhibitor | 0.413 0.025 CID_154699522 | CID_154699522 | |
| 0.221 | 0.017 | 0.221 | Arachidonic acid antagonist | 0.137 0.105 CID_154699522 | ||
| 0.265 | 0.063 | 0.532 | Free radical scavenger | 0.532 0.013 CID_154699522 | CID_154699522 | |
| 0.223 | 0.033 | 0.223 | Succinate dehydrogenase inhibitor | |||
| 0.27 | 0.08 | 0.274 | 5 Hydroxytryptamine release stimulant | 0.274 0.079 CID_154699522 | CID_154699522 | |
| 0.196 | 0.011 | 0.196 | TRPA1 agonist | 0.175 0.018 CID_154699522 | ||
| 0.239 | 0.057 | 0.239 | RNA-directed DNA polymerase inhibitor | 0.229 0.065 CID_154699522 | ||
| 0.185 | 0.004 | 0.206 | Glycine receptor antagonist | 0.206 0.003 CID_154699522 | CID_154699522 | |
| 0.194 | 0.014 | 0.195 | Vanilloid 1 agonist | 0.195 0.013 CID_154699522 | CID_154699522 | |
| 0.225 | 0.052 | 0.469 | Hepatoprotectant | 0.469 0.009 CID_154699522 | CID_154699522 | |
| 0.185 | 0.018 | 0.21 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.21 0.014 CID_154699522 | CID_154699522 | |
| 0.172 | 0.009 | 0.172 | T cell inhibitor | 0.098 0.026 CID_154699522 | ||
| 0.17 | 0.009 | 0.17 | Anabolic | 0.092 0.075 CID_154699522 | ||
| 0.183 | 0.023 | 0.183 | Adenylate cyclase stimulant | 0.133 0.094 CID_154699522 | ||
| 0.165 | 0.005 | 0.165 | ATPase (Vacuolar H+) inhibitor | 0.152 0.007 CID_154699522 | ||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.167 0.015 CID_154699522 | ||
| 0.161 | 0.005 | 0.161 | Glycine receptor agonist | 0.15 0.007 CID_154699522 | ||
| 0.269 | 0.116 | 0.411 | Vasodilator, coronary | 0.411 0.032 CID_154699522 | CID_154699522 | |
| 0.161 | 0.022 | 0.39 | AMP-activated protein kinase stimulant | 0.39 0.004 CID_154699522 | CID_154699522 | |
| 0.149 | 0.011 | 0.149 | Ornithine decarboxylase inhibitor | 0.104 0.04 CID_154699522 | ||
| 0.224 | 0.094 | 0.59 | Hypoglycemic | 0.59 0.009 CID_154699522 | CID_154699522 | |
| 0.137 | 0.009 | 0.156 | Na+ K+ transporting ATPase inhibitor | 0.156 0.005 CID_154699522 | CID_154699522 | |
| 0.251 | 0.127 | 0.251 | Vasodilator, peripheral | 0.248 0.129 CID_154699522 | ||
| 0.141 | 0.018 | 0.215 | Transcription factor NF kappa B stimulant | 0.215 0.008 CID_154699522 | CID_154699522 | |
| 0.209 | 0.088 | 0.41 | Peptidyltransferase inhibitor | 0.41 0.006 CID_154699522 | CID_154699522 | |
| 0.249 | 0.129 | 0.249 | Sodium/bile acid cotransporter inhibitor | |||
| 0.126 | 0.008 | 0.126 | 5-Alpha-reductase inhibitor | 0.045 0.021 CID_154699522 | ||
| 0.174 | 0.056 | 0.174 | Acetylcholine M1 receptor antagonist | |||
| 0.148 | 0.032 | 0.2 | Photosensitizer | 0.2 0.013 CID_154699522 | CID_154699522 | |
| 0.195 | 0.081 | 0.195 | Neurotrophic factor enhancer | 0.176 0.103 CID_154699522 | ||
| 0.12 | 0.009 | 0.26 | Protein 50S ribosomal subunit inhibitor | 0.26 0.004 CID_154699522 | CID_154699522 | |
| 0.154 | 0.044 | 0.306 | Alkylator | 0.306 0.012 CID_154699522 | CID_154699522 | |
| 0.133 | 0.026 | 0.206 | Triose-phosphate isomerase inhibitor | 0.206 0.01 CID_154699522 | CID_154699522 | |
| 0.129 | 0.023 | 0.129 | CYP2A6 inhibitor | |||
| 0.12 | 0.016 | 0.12 | HIV-1 integrase (Strand Transfer) inhibitor | 0.094 0.025 CID_154699522 | ||
| 0.156 | 0.054 | 0.156 | Neurotrophic factor | 0.115 0.104 CID_154699522 | ||
| 0.111 | 0.01 | 0.111 | Vanilloid 4 agonist | |||
| 0.132 | 0.035 | 0.132 | Adenylate kinase inhibitor | |||
| 0.139 | 0.042 | 0.139 | Ferrochelatase inhibitor | |||
| 0.124 | 0.028 | 0.124 | ABCA1 expression enhancer | |||
| 0.169 | 0.074 | 0.169 | Phospholipase C inhibitor | |||
| 0.123 | 0.032 | 0.123 | Androgen antagonist | |||
| 0.147 | 0.056 | 0.147 | Farnesoid X receptor antagonist | |||
| 0.129 | 0.039 | 0.129 | Estrogen antagonist | |||
| 0.14 | 0.05 | 0.142 | Protein-tyrosine phosphatase 1B inhibitor | 0.142 0.049 CID_154699522 | CID_154699522 | |
| 0.114 | 0.027 | 0.21 | Phosphofructokinase-1 inhibitor | 0.21 0.01 CID_154699522 | CID_154699522 | |
| 0.118 | 0.031 | 0.118 | mTOR complex 1 inhibitor | |||
| 0.09 | 0.003 | 0.09 | Kainate receptor agonist | 0.046 0.019 CID_154699522 | ||
| 0.103 | 0.018 | 0.103 | Biliverdin reductase inhibitor | |||
| 0.168 | 0.083 | 0.168 | Lipocortins synthesis antagonist | |||
| 0.217 | 0.133 | 0.255 | Hypoxia-inducible factor 1 alpha inhibitor | 0.255 0.096 CID_154699522 | CID_154699522 | |
| 0.107 | 0.024 | 0.107 | Estrogen receptor alpha antagonist | |||
| 0.086 | 0.004 | 0.086 | Parathyroid hormone antagonist | |||
| 0.145 | 0.063 | 0.145 | Pregnane X receptor agonist | |||
| 0.173 | 0.092 | 0.199 | Anesthetic general | 0.199 0.075 CID_154699522 | CID_154699522 | |
| 0.241 | 0.162 | 0.241 | GABA C receptor rho-3 antagonist | |||
| 0.12 | 0.043 | 0.208 | UDP-glucose 4-epimerase inhibitor | 0.208 0.017 CID_154699522 | CID_154699522 | |
| 0.101 | 0.028 | 0.114 | Interferon agonist | 0.114 0.02 CID_154699522 | CID_154699522 | |
| 0.099 | 0.027 | 0.105 | GABA aminotransferase inhibitor | 0.105 0.023 CID_154699522 | CID_154699522 | |
| 0.144 | 0.072 | 0.363 | Cell wall synthesis inhibitor | 0.363 0.007 CID_154699522 | CID_154699522 | |
| 0.166 | 0.094 | 0.166 | P-glycoprotein inhibitor | 0.152 0.114 CID_154699522 | ||
| 0.088 | 0.018 | 0.098 | Interferon inducer | 0.098 0.013 CID_154699522 | CID_154699522 | |
| 0.071 | 0.004 | 0.071 | Vitamin D receptor antagonist | |||
| 0.112 | 0.044 | 0.112 | DNA directed RNA polymerase inhibitor | |||
| 0.071 | 0.004 | 0.071 | Tubulin agonist | 0.046 0.01 CID_154699522 | ||
| 0.085 | 0.019 | 0.085 | Glutamate (mGluR6) antagonist | |||
| 0.067 | 0.002 | 0.112 | Vanilloid 2 agonist | 0.112 0.001 CID_154699522 | CID_154699522 | |
| 0.128 | 0.064 | 0.128 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.116 | 0.053 | 0.116 | Electron transport complex I inhibitor | |||
| 0.072 | 0.012 | 0.072 | Kainate receptor antagonist | |||
| 0.198 | 0.139 | 0.198 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.079 | 0.021 | 0.079 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.064 0.031 CID_154699522 | ||
| 0.067 | 0.008 | 0.067 | Microtubule stabilization | 0.063 0.012 CID_154699522 | ||
| 0.091 | 0.033 | 0.091 | CDC25A inhibitor | |||
| 0.068 | 0.011 | 0.068 | Retinoid X receptor agonist | |||
| 0.14 | 0.083 | 0.268 | NOS3 expression enhancer | 0.268 0.023 CID_154699522 | CID_154699522 | |
| 0.067 | 0.01 | 0.067 | TRPM8 blocker | |||
| 0.112 | 0.055 | 0.112 | GABA C receptor agonist | |||
| 0.144 | 0.088 | 0.144 | CF transmembrane conductance regulator agonist | |||
| 0.105 | 0.054 | 0.105 | Estrogen receptor beta antagonist | |||
| 0.064 | 0.015 | 0.064 | Adenylate cyclase 1 inhibitor | |||
| 0.087 | 0.039 | 0.087 | Glutamate dehydrogenase inhibitor | |||
| 0.096 | 0.048 | 0.137 | NADH dehydrogenase inhibitor | 0.137 0.021 CID_154699522 | CID_154699522 | |
| 0.072 | 0.025 | 0.072 | Calcium channel P-type blocker | |||
| 0.125 | 0.081 | 0.125 | Bone formation stimulant | |||
| 0.069 | 0.025 | 0.069 | Sphingosine kinase inhibitor | |||
| 0.048 | 0.005 | 0.048 | CYP24 inhibitor | |||
| 0.189 | 0.149 | 0.189 | Transcription factor STAT3 inhibitor | |||
| 0.068 | 0.028 | 0.068 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.084 | 0.044 | 0.084 | Keratolytic | |||
| 0.134 | 0.097 | 0.137 | Protein-tyrosine phosphatase inhibitor | 0.137 0.093 CID_154699522 | CID_154699522 | |
| 0.09 | 0.055 | 0.09 | Antineoplastic alkaloid | |||
| 0.068 | 0.034 | 0.068 | Transcription factor RelA inhibitor | |||
| 0.159 | 0.128 | 0.329 | Hypolipemic | 0.329 0.041 CID_154699522 | CID_154699522 | |
| 0.045 | 0.015 | 0.045 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.054 | 0.025 | 0.063 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 CID_154699522 | CID_154699522 | |
| 0.094 | 0.064 | 0.094 | Bile acid receptor antagonist | |||
| 0.064 | 0.036 | 0.064 | Androgen agonist | |||
| 0.06 | 0.032 | 0.06 | Pregnane X receptor antagonist | |||
| 0.081 | 0.053 | 0.081 | Acetylcholine nicotinic antagonist | |||
| 0.057 | 0.031 | 0.057 | Estrogen agonist | 0.051 0.035 CID_154699522 | ||
| 0.067 | 0.041 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.063 0.044 CID_154699522 | ||
| 0.039 | 0.014 | 0.039 | Adenosine uptake inhibitor | 0.037 0.018 CID_154699522 | ||
| 0.033 | 0.008 | 0.033 | Prostaglandin F2 alpha agonist | |||
| 0.172 | 0.148 | 0.173 | Nitric-oxide synthase stimulant | 0.173 0.145 CID_154699522 | CID_154699522 | |
| 0.038 | 0.017 | 0.038 | HMG CoA reductase inhibitor | |||
| 0.05 | 0.029 | 0.05 | Aldosterone antagonist | |||
| 0.08 | 0.062 | 0.08 | Inducible nitric-oxide synthase inhibitor | |||
| 0.058 | 0.041 | 0.066 | Lipocortins synthesis agonist | 0.066 0.025 CID_154699522 | CID_154699522 | |
| 0.028 | 0.012 | 0.028 | Glutamate (mGluR1) agonist | |||
| 0.04 | 0.025 | 0.04 | Retinoic acid alpha receptor agonist | |||
| 0.019 | 0.004 | 0.019 | Calcineurin inhibitor | 0.011 0.008 CID_154699522 | ||
| 0.053 | 0.038 | 0.078 | Alpha-mannosidase inhibitor | 0.078 0.012 CID_154699522 | CID_154699522 | |
| 0.036 | 0.022 | 0.036 | Estrogen receptor beta agonist | |||
| 0.039 | 0.025 | 0.039 | Vanilloid 3 antagonist | |||
| 0.196 | 0.182 | 0.576 | Antithrombotic | 0.576 0.019 CID_154699522 | CID_154699522 | |
| 0.053 | 0.042 | 0.053 | Alcohol oxidase inhibitor | |||
| 0.057 | 0.046 | 0.057 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.032 | 0.022 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.021 | 0.011 | 0.021 | Progesterone receptor B antagonist | |||
| 0.032 | 0.023 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.041 | 0.032 | 0.045 | Guanylate cyclase inhibitor | 0.045 0.026 CID_154699522 | CID_154699522 | |
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | |||
| 0.052 | 0.044 | 0.052 | Sphingosine kinase 2 inhibitor | |||
| 0.018 | 0.01 | 0.025 | Telomerase stimulant | 0.025 0.004 CID_154699522 | CID_154699522 | |
| 0.016 | 0.009 | 0.029 | Antibiotic Macrolide-like | 0.029 0.004 CID_154699522 | CID_154699522 | |
| 0.019 | 0.012 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.051 | 0.045 | 0.051 | Argininosuccinate synthase inhibitor | |||
| 0.085 | 0.079 | 0.085 | Creatine kinase inhibitor | |||
| 0.088 | 0.082 | 0.088 | GABA C receptor rho-1 antagonist | |||
| 0.073 | 0.068 | 0.073 | MAP kinase kinase 7 inhibitor | |||
| 0.091 | 0.086 | 0.158 | Toll-Like receptor 4 antagonist | 0.158 0.017 CID_154699522 | CID_154699522 | |
| 0.032 | 0.028 | 0.032 | Kainate receptor 2 antagonist | |||
| 0.026 | 0.022 | 0.026 | Retinoid X gamma receptor antagonist | |||
| 0.021 | 0.018 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.177 | 0.173 | 0.177 | Transcription factor STAT inhibitor | |||
| 0.027 | 0.023 | 0.027 | RNA-directed RNA polymerase stimulant | |||
| 0.005 | 0.002 | 0.005 | Vitamin D-like | |||
| 0.056 | 0.053 | 0.056 | Ryanodine receptor antagonist | |||
| 0.024 | 0.022 | 0.05 | Sodium/glucose cotransporter inhibitor | 0.05 0.005 CID_154699522 | CID_154699522 | |
| 0.064 | 0.062 | 0.064 | Porphobilinogen synthase inhibitor | |||
| 0.018 | 0.016 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_154699522 | CID_154699522 | |
| 0.021 | 0.02 | 0.021 | Retinoic acid receptor agonist | |||
| 0.017 | 0.016 | 0.017 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.024 | 0.023 | 0.055 | Sodium/glucose cotransporter 2 inhibitor | 0.055 0.005 CID_154699522 | CID_154699522 | |
| 0.101 | 0.102 | 0.242 | Cyclooxygenase 3 inhibitor | 0.242 0.01 CID_154699522 | CID_154699522 | |
| 0.086 | 0.087 | 0.248 | Monophenol monooxygenase inhibitor | 0.248 0.024 CID_154699522 | CID_154699522 | |
| 0.105 | 0.11 | 0.141 | Interleukin 4 antagonist | 0.141 0.059 CID_154699522 | CID_154699522 | |
| 0.014 | 0.02 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_154699522 | CID_154699522 | |
| 0.037 | 0.045 | 0.068 | Mannosidase inhibitor | 0.068 0.013 CID_154699522 | CID_154699522 | |
| 0.083 | 0.103 | 0.169 | Beta glucuronidase inhibitor | 0.169 0.018 CID_154699522 | CID_154699522 | |
| 0.135 | 0.162 | 0.314 | Platelet antagonist | 0.314 0.048 CID_154699522 | CID_154699522 | |
| 0.026 | 0.055 | 0.08 | Antibiotic Aminoglycoside-like | 0.08 0.004 CID_154699522 | CID_154699522 | |
| 0.014 | 0.053 | 0.063 | Protein 30S ribosomal subunit inhibitor | 0.063 0.005 CID_154699522 | CID_154699522 | |
| 0.067 | 0.113 | 0.081 | Interleukin 5 antagonist | 0.081 0.071 CID_154699522 | CID_154699522 | |
| 0.041 | 0.091 | 0.068 | Nitric oxide donor | 0.068 0.036 CID_154699522 | CID_154699522 | |
| 0.038 | 0.098 | 0.051 | Factor III inhibitor | 0.051 0.032 CID_154699522 | CID_154699522 | |
| 0.009 | 0.07 | 0.028 | Squalene synthetase inhibitor | 0.028 0.026 CID_154699522 | CID_154699522 | |
| 0.13 | 0.194 | 0.213 | Cyclic AMP phosphodiesterase inhibitor | 0.213 0.084 CID_154699522 | CID_154699522 | |
| 0.068 | 0.146 | 0.24 | Amylase inhibitor | 0.24 0.031 CID_154699522 | CID_154699522 | |
| 0.029 | 0.108 | 0.34 | Selectin antagonist | 0.34 0.004 CID_154699522 | CID_154699522 | |
| 0.065 | 0.145 | 0.11 | DNA polymerase I inhibitor | 0.11 0.076 CID_154699522 | CID_154699522 | |
| 0.031 | 0.116 | 0.047 | Cytokine production stimulant | 0.047 0.038 CID_154699522 | CID_154699522 | |
| 0.014 | 0.103 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.011 CID_154699522 | CID_154699522 | |
| 0.09 | 0.191 | 0.235 | Insulin secretagoues | 0.235 0.023 CID_154699522 | CID_154699522 | |
| 0.061 | 0.162 | 0.099 | Xanthine oxidase inhibitor | 0.099 0.06 CID_154699522 | CID_154699522 | |
| 0.025 | 0.127 | 0.068 | Neuraminidase inhibitor | 0.068 0.035 CID_154699522 | CID_154699522 | |
| 0.189 | 0.292 | 0.615 | Cyclophilin D inhibitor | 0.615 0.025 CID_154699522 | CID_154699522 | |
| 0.037 | 0.147 | 0.171 | Topoisomerase II alpha inhibitor | 0.171 0.019 CID_154699522 | CID_154699522 | |
| 0.196 | 0.314 | 0.258 | 5 Hydroxytryptamine release inhibitor | 0.258 0.218 CID_154699522 | CID_154699522 | |
| 0.038 | 0.181 | 0.207 | Topoisomerase I inhibitor | 0.207 0.025 CID_154699522 | CID_154699522 | |
| 0.027 | 0.172 | 0.069 | Neuraminidase (influenza) inhibitor | 0.069 0.037 CID_154699522 | CID_154699522 | |
| 0.054 | 0.214 | 0.212 | Lipid peroxidase inhibitor | 0.212 0.037 CID_154699522 | CID_154699522 | |
| 0.075 | 0.236 | 0.152 | Hexokinase inhibitor | 0.152 0.077 CID_154699522 | CID_154699522 | |
| 0.017 | 0.193 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.038 CID_154699522 | CID_154699522 | |
| 0.024 | 0.207 | 0.074 | Heparanase inhibitor | 0.074 0.009 CID_154699522 | CID_154699522 | |
| 0.033 | 0.224 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.029 CID_154699522 | CID_154699522 | |
| 0.047 | 0.251 | 0.124 | Beta amyloid protein antagonist | 0.124 0.063 CID_154699522 | CID_154699522 | |
| 0.129 | 0.337 | 0.38 | Histamine release inhibitor | 0.38 0.086 CID_154699522 | CID_154699522 | |
| 0.034 | 0.258 | 0.228 | Topoisomerase II inhibitor | 0.228 0.028 CID_154699522 | CID_154699522 | |
| 0.036 | 0.303 | 0.275 | Thrombolytic | 0.275 0.028 CID_154699522 | CID_154699522 | |
| 0.019 | 0.3 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 CID_154699522 | CID_154699522 | |
| 0.08 | 0.363 | 0.236 | Alpha-glucosidase inhibitor | 0.236 0.196 CID_154699522 | CID_154699522 | |
| 0.013 | 0.334 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_154699522 | CID_154699522 | |
| 0.04 | 0.368 | 0.207 | Cell adhesion inhibitor | 0.207 0.023 CID_154699522 | CID_154699522 | |
| 0.047 | 0.424 | 0.154 | Interleukin 6 antagonist | 0.154 0.083 CID_154699522 | CID_154699522 | |
| 0.043 | 0.439 | 0.136 | Hemostatic | 0.136 0.087 CID_154699522 | CID_154699522 | |
| 0.005 | 0.414 | 0.022 | Motilin receptor agonist | 0.022 0.018 CID_154699522 | CID_154699522 | |
| 0.072 | 0.655 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 CID_154699522 | CID_154699522 | |
| 0.008 | 0.74 | 0.156 | Anticoagulant | 0.156 0.075 CID_154699522 | CID_154699522 | |
| 0.009 | 0.889 | 0.049 | Factor IXa inhibitor | 0.049 0.04 CID_154699522 | CID_154699522 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |